| Literature DB >> 29384983 |
George S Stergiou1, Bruce Alpert2, Stephan Mieke3, Roland Asmar4, Neil Atkins5, Siegfried Eckert6, Gerhard Frick7, Bruce Friedman8, Thomas Graßl9, Tsutomu Ichikawa10, John P Ioannidis11, Peter Lacy12, Richard McManus13, Alan Murray14, Martin Myers15, Paolo Palatini16, Gianfranco Parati17, David Quinn18, Josh Sarkis19, Andrew Shennan20, Takashi Usuda21, Jiguang Wang22, Colin O Wu23, Eoin O'Brien24.
Abstract
: In the last 30 years, several organizations, such as the US Association for the Advancement of Medical Instrumentation (AAMI), the British Hypertension Society, the European Society of Hypertension (ESH) Working Group on Blood Pressure (BP) Monitoring and the International Organization for Standardization (ISO) have developed protocols for clinical validation of BP measuring devices. However, it is recognized that science, as well as patients, consumers and manufacturers would be best served if all BP measuring devices were assessed for accuracy according to an agreed single validation protocol that had global acceptance. Therefore, an international initiative was taken by AAMI, ESH and ISO experts who agreed to develop a universal standard for device validation. This statement presents the key aspects of a validation procedure, which were agreed by the AAMI, ESH and ISO representatives as the basis for a single universal validation protocol. As soon as the AAMI/ESH/ISO standard is fully developed, this will be regarded as the single universal standard and will replace all other previous standards/protocols.Entities:
Mesh:
Year: 2018 PMID: 29384983 PMCID: PMC5796427 DOI: 10.1097/HJH.0000000000001634
Source DB: PubMed Journal: J Hypertens ISSN: 0263-6352 Impact factor: 4.844